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Transgenic mice expressing the E7 protein of HPV16 from the keratin 14 promoter demonstrate
increasing thymic hypertrophy with age. This hypertrophy is associated with increased absolute
numbers of all thymocyte types, and with increased cortical and medullary cellularity. In the thymic
medulla, increased compartmentalization of the major thymic stromal cell types and expansion of
thymic epithelial cell population is observed. Neither an increased rate of immature thymocyte division
nor a decreased rate of immature thymocyte death was able to account for the observed hypertrophy.
Thymocytes with reduced levels of expression of CD4 and/or CD8 were more abundant in transgenic
(tg) mice and became increasingly more so with age. These thymic SP and DP populations with reduced
levels of CD4 and/or CD8 markers had a lower rate of apoptosis in the tg than in the non-tg mice.
The rate of export of mature thymocytes to peripheral lymphoid organs was less in tg animals relative to
the pool of available mature cells, particularly for the increasingly abundant CD4lo population.
We therefore suggest that mature thymocytes that would normally die in the thymus gradually
accumulated in E7 transgenic animals, perhaps as a consequence of exposure to a hypertrophied
E7-expressing thymic epithelium or to factors secreted by this expanded thymic stromal cell
population. The K14E7 transgenic mouse thus provides a unique model to study effects of the thymic
epithelial cell compartment on thymus development and involution.
Keywords: Thymus; T lymphocyte; Cellular differentiation; Transgenic
Abbreviations: tg, transgenic; TN, triple negative; DP, double positive; SP, single positive; HSA, heat
shock antigen; TEC, thymic epithelial cells; K5, keratin 5; K14E7, FVB mice transgenic for the E7
protein of Human Papillo ma virus type 16 driven off the keratin promoter; BrdU, 5-bromo-20-
deoxyuridine; PI, propidium iodine; LN, lymph node; AAD, amino actinomycin D
INTRODUCTION
T cell precursors first enter the cortex of the thymus from
the bone marrow and subsequently go through four
discrete developmental stages within the CD42CD82
CD32 triple negative (TN) T cell precursor population.
The most immature TN thymocytes (TN1), defined by
their CD44þCD252 staining pattern, give rise to the TN2
CD44þCD25þ subset. TCR rearrangements begin at this
stage and once the cells pass to the TN3 (CD442CD25þ)
stage they are committed to the T cell lineage. Following
downregulation of CD25 in the final TN4 stage, they
develop into the predominant thymic population which
expresses neither CD25 nor CD44 and is double positive
(DP) for the expression of CD4 and CD8. Further
rearrangement occurs and the DP cells move into the
medullary area as either CD4þ single positive (SP) or
CD8þ SP. During their time in the medulla there is
modification of additional markers such as CD69, heat
shock antigen (HSA), L-selectin and CD45RB, as they
await export to the periphery (Gabor et al., 1997b).
Interplay between thymocytes, thymic epithelium and
other cells of the thymic stroma regulate both thymic
development and T cell maturation. Signals provided by
the thymic epithelium regulate the passage of thymocytes
through developmental checkpoints. Thymic involution
occurs in the maturing animal, and is associated with a
progressive loss of thymus cortex and normal thymic
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architecture, with a decline in the output of mature T cells.
With increasing age, there is also a decline in the capacity
of the thymus to support T cell differentiation, the
composition of the peripheral T cell compartment
changes, and there is a loss of immune function
(Utsuyama et al., 1991; Thoman, 1995).
Disturbance of the stromal or T cell components of
the thymus by targeted transgene expression has been
used previously to analyze the factors controlling
thymus and thymocyte development. In the model
presented here, targeted expression of the human
papillomavirus 16 oncogenic E7 protein to basal
epidermal keratinocytes has produced an animal in
which the thymus fails to involute and becomes
progressively hypertrophic with age. These mice have
relatively normal antibody and T helper cell responses
to E7 and other antigens and have no evidence of
autoimmunity to the E7 expressed in their thymus or
skin (Frazer et al., 1998). A reduced CD8þ E7-specific
and non-E7 specific CD8þ CTL response is the only
immunological consequence of expression of their
transgene reported to this point (Tindle et al., 2001).
Other tg mice exhibiting thymic hypertrophy include
the K5-cyclin D1 and the K5 HPV16E6/E7 tg mice. An
expanded cortical thymic epithelial cell (TEC) precursor
compartment in the cyclin D1 mice provides an increased
availability of developmental niches for maturing pre-T
cells (Klug et al., 2000). An increased rate of early
thymocyte cycling leads to an expanded thymus contain-
ing a normal thymocyte subset distribution. Similarly, the
deregulation of epithelial cell proliferation through the
expression of HPV16 E6/E7 in the keratin 5 (K5)
precursor epithelial compartment of the recently described
K5 HPV16E6/E7 tg mice did not alter the outcome of T
cell differentiation (Carraresi et al., 2001). The observed
normal T cell development in both strains of tg mice was
attributed to the continuing expansion of a thymic niche
supportive of early stage T cell development. In contrast,
the Human CD3e transgenic mice, in which the minor
cortical subset K8þK18þK5þK142 is the predominant
epithelial subset, develop a poorly organized, primitive
thymus in which thymocyte development is inhibited at
the CD44þCD252 pro T cell stage (Hollander et al.,
1995). The lack of developmental niches for the later
stages of T cell maturation resulting in a very small
thymus lacking CD4þ and CD8þ SP thymocytes. K14 is a
keratin isoform selectively expressed in mature thymic
epithelium. By analogy with the effects of E7 as a
transgene in other cell types, expression of the oncogenic
E7 protein in the thymic epithelium of the K14E7 mice
would likely induce a selective expansion of this mature
K14þ TEC compartment. Such an expansion may produce
a thymus more able to support late stage T cell
development. A study of the T cell developmental in a
mouse in which the thymic microenvironment is altered in
this way may thus shed further light on the effect of
stromal cell composition upon T cell maturation and
thymic function.
MATERIALS AND METHODS
Mice
FVB and FVB mice transgenic for the E7 protein of
Human Papilloma virus type 16 driven off the keratin
promoter (K14E7) (Herber et al., 1996) were obtained
from the Animal Research Centre, Perth, and were housed
under specific pathogen free conditions.
Measurement of E7 mRNA
HPV16 E7 mRNA was measured by real time polymerase
chain reaction of reverse transcriptase generated cDNA
using the Perkin Elmer Taqman system as described
elsewhere (Frazer et al., 2001). Briefly, PCR of 150 ng of
sample mRNA was performed using E7 specific primers
and E7 mRNA estimations based on a standard curve
derived from serial dilutions of plasmid pHPV16.
Histology
Gross thymic architecture was assessed by staining slides
made from paraffin-embedded thymii of 6 month old FVB
and K14E7 mice with hematoxylin and eosin. Thymii
from mice of this age were also snap frozen in O.C.T.
Compound (Tissue-Tek, Sakura, Tokyo) for later cryostat
processing. These mice had been injected intraperitone-
ally with 100 mg/kg body weight 5-bromo-20-deoxy-
uridine (BrdU) (Sigma) in PBS at 0 and 4 h and sacrificed
at 5 h. Five micrometer sections were cut and stained with
FITC labeled anti -BrdU (Pharmingen) in addition to anti-
K14, -K8, -CD3,-MTS 7 and MTS 15 (as described
below). Sections were stained as a two or three step
process. Anti-keratins were biotinylated and therefore
required streptavidin conjugated-alexa-488 (green), -cy-5
(blue) or -alexa 568 (red) as tertiary antibodies. CD3 and
antigens of the MTS series were detected in a two step
process using rat primary antibodies and anti rat-alexa-
488, -alexa 568 and -cy-5 as above.
Cell Suspensions
Single cell thymic preparations were made by following a
30 min digestion in a 1 mg/ml solution of Collagenase A
(Boehringer Mannheim) in PBS at 378C. Red blood cells
were remove d from both thymic and lymph node (LN)
preparations following incubation in 1 ml ACK lysis
buffer (0.15 M NH4Cl, 1 M KHCO3, 0.1 mM EDTA) for
2 min at room temperature, followed by a wash in ice cold
PBS-FCS 1%.
Flow Cytometry
Single cell suspensions of thymic and LN cells were
stained with mAbs as described in Rodewald et al. (1995).
Data on 105 cells per test were collected using a Fascalibur
(Becton Dickinson, Mountain View, CA) and analyzed
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using CellQuest (Becton Dickinson) software. In situations
were the number of cells in a particular gate were very
small, the total number of cells collected per test was
increased in order to give an accurate measurement.
Analyzed cells were selectively gated on forward light
scatter versus side light scatter to eliminate dead cells and
debris from analysis. An EPICS Elite ESP flow cytometer
(Coulter, Hiateah, FL, USA) was used to separate
individual cell populations based upon their CD25/CD44
or CD4/CD8 staining patterns.
Antibodies
Unless otherwise noted, all antibodies were purchased
from PharMingen (San Diego, CA). For flow cytometric
analysis the following antibodies were used: FITC-labeled
CD25, biotinylated CD44/ PerCP labeled Streptavidin,
CD3 APC and CD11b APC, PE labeled CD4, biotinylated
CD8/ APC labeled Streptavidin, PerCP labeled CD3, anti-
BrdU-FITC, biotinylated CD3/ PerCP labeled strepta-
vidin, APC labeled CD8, PE labeled CDllb, and APC
labeled CD25. Thymic emigration rate experiments used
FITC isomer 1 (for intrathymic injection, purchased from
Becton Dickinson). Rabbit antisera specific for mouse
K14 (Roop et al., 1984) was obtained from Covance
Research (Richmond, CA). Thymic stromal antibodies of
the MTS series, prepared as rabbit polyclonal serum, have
been described elsewhere (Godfrey et al., 1990; Gray
et al., 2002). TN thymocytes were selectively analyzed
by excluding cells which stained positive for a cocktail
of FITC- labeled antibodies which included anti-Gr1,
-Mac-1, -CD3, -CD4, -CD8 and -B220.
Intrathymic Labeling
The technique us ed to FITC label thymocytes has been
described elsewhere (Berzins et al., 1999). Each lobe was
injected with approximately 10ml of 350mg/ml FITC.
Mice were killed by CO2 asphyxiation 24 h postinjection
and thymii, LN and spleen taken for analysis. The
migration of thymocytes to the periphery was determined
by calculating the number of FITC positive cells in the
peripheral lymphoid organs 24 h following intrathymic
labeling as a fraction of the total number of thymocytes
labeled (Scollay et al., 1980).
BrdU Measurement of Proliferation
Mice were injected intraperitoneally with BrdU as above.
Thymus, spleen and peripheral LN were then removed
into PBS-FCS 1%. Cell suspensions of these organs were
counted, washed and stained for FACS for differential
analysis of the proliferation of individual subpopulations.
Following staining for cell surface markers, each test was
resuspended in 100ml PBS-FCS 1%. One milliliter of 1%
paraformaldehyde was added dropwise to this suspension
and the cells were then incubated overnight at 48C. The
following day the cells were washed twice in PBS-FCS
2% and permeabilized using 50 ml of a 0.0001% DNAase
in digestion buffer (2 M NaCl, 4.3 mM MgCl2). Cells
were incubated in a 378C water bath for 30 min and
subsequently washed three times in PBS-FCS 2%. 40ml of
anti-BrdU-FITC (at 1:2 in PBS-FCS 5–0.5% Tween-20)
was added to the washed cell pellet and incubated for
30 min at RT. Following two washes in PBS-FCS 2% the
cells were resuspended in 200ml wash buffer and analyzed
by FACS.
TUNEL analysis of apoptosis in whole tissue thymic
preparations: an in situ cell death detection kit (TUNEL)
(Boehringer Mannheim) was used according to the
manufacturer’s instructions.
TEC Enrichment
Thymic cell preparations were enriched for epithelium by
injecting the mice intraperitoneally 48 h prior to thymus
harvest with 0.5 mg cortisone per 20 g mouse (Dexa-
methasone sodium phosphate, David Bull Laboratories).
The thymic cell preparations were prepared as described
previously (Schreiber et al., 1991) and then cultured
overnight in 1.35 M deoxyguanosine to further deplete the
preparations of T cells.
Apoptosis within Cell Subpopulations
Cells which had been stained with the anti- CD25, -CD44,
-CD4 and -CD8 Mabs as described above were subsequently
stained with a 7-amino-actinomycin D (7-AAD) solution
(Viaprobe, BD PharMingen), used according to the
manufacturers instructions. This allowed a determination
of the dead and dying cells within the subpopulations.
Cell Cycle Analysis
Fresh thymocytes were stained for surface marker
expression in the usual way and then stained with propidium
iodide (PI) according to the method outlined in Current
Protocols in Immunology (1999). Data was collected on the
FACScalibur in linear mode for cell cycle analysis.
RESULTS
The K14E7 Mouse Thymus Fails to Involute
Post-puberty
The Human Papillomavirus type 16 E7 gene is driven off
a keratin 14 promoter in a line of K14E7 transgenic
FVB mice (Herber et al., 1996). Using Real-Time PCR,
E7 mRNA could be detected in these animals in skin,
thymus, upper digestive tract and stomach. The skin and
thymus had 8.3 ^ 0.5 £ 10 5 and 7.2 ^ 0.5 £ 10 5 copies
of E7 mRNA per ng total mRNA, respectively.
Compared with non-transgenic FVB littermates, older
K14E7 tg mice exhibited thymic hypertrophy. Failure of
the K14E7 tg mouse thymus to undergo the normal
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involution which accompanies ageing was
followed by increased thymic weight and cellularity
(Fig. 1A,B). Thymii of more than 1 g and 109 cells were
observed in some 12 month old animals. The absolute
number of cells per spleen or LN was approximately 1.5
times greater in the adult K14E7 mice than in non-
transgenic FVB mice (from 3 months of age).
Thymic hypertrophy similar to that observed in
K14E7tg FVB mice was observed in C57Bl/6 mice
expressing the same transgene construct. The effects of E7
on cell growth and differentiation are abolished by
mutations at the CKII site (Davies et al., 1993; Demers
et al., 1996) and mice transgenic for a mutant E7 lacking a
functional CKII site, driven from the K14 promoter did
not develop enlarged thymii. Failure of involution, and
subsequent hypertrophy of the thymus of the K14E7 tg
mouse, is thus likely to be a consequence of the production
of biologically active E7 in the thymus.
Expression of the E7 Transgene Alters Thymic
Architecture
Expression of a K14-controlled transgene would be
expected to be most evident in the thymic medulla area
where K14þ epithelial cells are found (Klug et al., 1998;
Burns et al., 1999), though it is noted that transgenes
driven from the K14 promoter are sometimes expressed
ectopically in the cortical epithelium (McGargill et al.,
2000). Gross architectural changes in the K14E7 tg mouse
thymus were, evident in both cortical and medullary areas
(Fig. 2A,B). K14E7 tg lobes were more cellular than were
non-tg lobes, with the cortical regions significantly
expanded. Medullary thymocytes especially were much
more densely arranged (Fig. 2A,B, inset).
Reduced Levels of Expression of CD4 and CD8 on
K14E7 tg Thymocytes
The CD4þCD8þ (DP) and CD4þCD82 or CD42CD8þ
(SP) populations are represented in relatively normal
proportions in K14E7 tg mice (Fig. 3). Further, the ratio of
mature SP CD4 to SP CD8 T cells was similar for FVB
and K14E7 mice, in both the thymus and the LN (data not
shown). Reduced levels of CD4 and CD8 expression per
cell was observed within the SP and DP populations in the
K14E7 tg thymus from 6 weeks of age, becoming more
apparent in older mice (Fig. 3), particularly in the CD3hi
population. Reduced CD4 and CD8 expression levels were
FIGURE 1 Failure of the K14E7 mouse thymus to involute with age. Thymic weight (A) and cellularity (B) are shown for K14E7 tg and non-tg FVB
thymus. Weights and cell counts are the means ^ SEM for 4–5 mice at each age.
FIGURE 2 Expression of the HPV16E7 transgene in the K14E7 thymus causes gross architectural changes. Hematoxylin and eosin stain of
formaldehyde-fixed sections from 6 month old FVB (A) and K14E7 (B) thymii. Expanded cortical regions (c) in the K14E7 thymus are accompanied by
more densely packed medullary regions (m) as shown in expanded magnifications of medullary areas at the arrowheads (Magnification, £ 400).
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also observed in peripheral lymphoid organs in older mice
(Table I).
The Cells with Lower Levels of CD4 and CD8
Expression have passed through Selection
CD69 surface expression was more frequent on DP
thymocytes in K14E7 tg (7.5 ^ 1.4%) than in FVB
(4.18 ^ 0.4%) animals. Also, more DP cells expressed
high levels of CD5 in tg mice (91.0 ^ 6.3%, mean level of
expression 221.1) than did non-tg animals (61.3 ^ 5.4%,
mean level of expression 123.2). As CD69 and
subsequently CD5 are upregulated on DP cells following
positive selection (Gabor et al., 1997a), the higher level of
expression of CD69 and CD5 in the K14E7 tg thymus
suggested that a greater proportion of the DP cells in tg
than the non-tg thymus have passed through selection.
There was no difference in the level of TCR expression
shown between FVB and K14E7 thymocytes.
The K14E7 Mouse Thymus is not Enlarged due to an
Increased Percentage of Cells in Cycle
Expression of functional but not mutated E7 was
associated with thymic hypertrophy, and E7 expression
directly increases the fraction of cells in cycle. Although
the K14 promoter is not generally active in lymphocytes,
and E7 mRNA was not detectable in BM derived cells in
the K14E7 tg mouse, low level ectopic E7 expression in
thymocytes might nevertheless expand the thymocyte
pool. However, incorporation of BrdU was observed in a
greater percentage of FVB than of K14E7 thymocytes,
BrdU incorporation was less in the CD4lo population than
in the CD4hi population in the K14E7 thymus, and less in
K14E7 CD4lo thymocytes than in FVB CD4lo thymocytes
(Table II). Thus, the increased cellularity and relative
preponderance of CD4lo thymocytes in the K14E7 thymus
could not be attributed to increased replication amongst
immature thymocytes.
FIGURE 3 CD4 and CD8 expression on E7tg thymic T cells is lower and the number of CD4lo and CD8lo cells increases with age. Thymic cell
preparations were from 6 week old (A and C) and 6 month old (B and D) FVB and K14E7 mice were stained with CD4 PE and biotinylated
CD8/Streptavidin APC. These figures shown the staining for four individual mice and are representative of four repeats of this experiment.
TABLE I Expression of CD4 and CD8 on LN cells expressing high levels of CD3
Mouse strain and age CD4hi CD4lo CD8hi CD8lo DPhi DPlo
FVB 6 weeks 75.6 ^ 3.0 0.5 ^ 0.0 17.6 ^ 2.5 0.1 ^ 0.0 1.9 ^ 0.1 0.2 ^ 0.0
K14E7 6 weeks 78.7 ^ 5.5 0.1 ^ 0.0 15.9 ^ 2.4 0.0 ^ 0.0 0.7 ^ 0.1 0.1 ^ 0.0
FVB 6 months 72.7 ^ 4.2 4.4 ^ 0.0 14.6 ^ 3.3 0.1 ^ 0.0 0.6 ^ 0.0 0.3 ^ 0.1
K14E7 6 months 61.9 ^ 7.5 12.4 ^ 0.5 8.7 ^ 0.7 0.9 ^ 0.1 2.3 ^ 0.1 0.8 ^ 0.1
Expressed as % positive cells, values are the mean ^ 1 S.D. calculated from three separate experiments.
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There is a Lower Proportion of Cells Undergoing
Apoptosis in K14E7 Tg Thymocytes with
Downregulated CD4 or CD8
We used 7AAD dye exclusion to examine the rate of cell
death in the K14E7 tg T cell populations. Since there were
a larger number of total cells in the K14E7 thymus, it is
not surprising that there were a significantly higher
number of thymocytes in the K14E7 than in the FVB mice
incorporating AAD (Fig. 4A). Thymocytes with lower
levels of CD4 and CD8 expression clearly have a higher
level of apoptosis in both tg and non-tg animals
(Fig. 4A). The percentage of cells incorporating AAD in
CD4lo and CD8lo populations was, however, lower in the
tg than the non-tg thymus. Further, a greater proportion
(1.5 times) of CD4lo than CD4hi cells were in G0/G1 in the
K14E7 thymus (Fig. 4D). This was not the case for the
FVB mouse where the majority of CD4lo cells were
undergoing apoptosis, a lesser proportion of cells being in
the resting G0/G1 phase. This is especially significant
since the CD4lo population accumulates dramatically in
K14E7 mice (Fig. 3). Thus, the accumulation of cells in
the K14E7 tg thymus is due, at least in part, to a reduced
level of cell death in a resting CD4lo compartment.
The lower levels of incorporation of AAD in the K14E7
subpopulation was not reflected in the level of
incorporation in the whole K14E7 thymus, which was
higher than that shown by the whole FVB thymus. This is
explained by AAD corporation studies on TEC enriched
thymic preparations which show that K14E7 TEC
populations incorporate AAD at a significantly higher
rate than do TEC populations from FVB thymii (Fig. 4C).
The K14E7 Thymus shows a Reduced Rate of Exit to
the Periphery for some Subpopulations of T Cells
Intrathymic labeling of tg and non-tg mice with
fluorescein followed by analysis of T cells in peripheral
lymphoid organs at 24 h was used to estimate exit rates for
thymocytes and selectivity of emigration to the periphery
(Scollay et al., 1980; Berzins et al., 1999). Intrathymic
labeling resulted in between 25 and 65% FITC positive
thymocytes. Accumulation in the LN of recent thymic
emigrants of all classes was reduced in the K14E7 tg
mouse when compared with non transgenic animals
(Table III). Although the CD4lo population was one which
became progressively larger in the tg thymus with age, the
peripheral accumulation of CD4lo cells from the K14E7
thymus occurred at a lower rate in the observed 24 h
period than accumulation of other cell types. We therefore
postulate that the accumulation of T cells in the K14E7 tg
thymus occurs as a result of enhanced survival of a post
selection CD4lo T cell population, together with a block to
their exit to the periphery.
In support of this, the rate of T cell emigration in K14E7
tg animals, relative to the size of the thymus decreased
with age. While the absolute number of recent thymic
emigrants accumulating in the peripheral LN was higher
in the older mice, the exit of cells expressing normal levels
of CD4 and CD8 was 3 fold higher than for CD4lo and
CD8lo cells.
The Earliest Stage of PreT Cell Development is more
Highly Represented in the K14E7 tg Thymus
In the 3 month old transgenic thymus, TN1 cells were
relatively overrepresented with a correspondingly reduced
late pre T cell (TN4–CD324282442252) compartment.
This difference was less obvious in older mice, reducing to
approximately 10% more TN1 and 10% fewer TN4 in the
K14E7 thymus.
CD44 and CD25 expression was similar on CD32
CD42CD82 pre T cells in young K14E7 tg and non-tg
FVB mice. From 12 months of age, however, CD44
expression levels were lower in the TN1
(CD32428244þ252) and TN2 (CD32428244þ25þ)
subpopulations of tg mice (Fig. 5B,C) than in non-
transgenic animals. C-kit expression was reduced in the
TN1 cells of K14E7 tg mice, mean expression for FVB
TN1 cells (whether expressing CD44hi or CD44lo) was
20.1 ^ 0.2%, the expression in K14E7 TN1 varied from
13.8 ^ 0.4 % for those CD44hi CD252 to 7.7 ^ 0.2 for
CD44lo CD252 TN1 cells Fig. 6.
The Overrespresented TN1 Population has a Higher
Level of Apoptosis
The transition from TN1 into TN2 cells has been shown
previously to be accompanied by an approximately
fivefold increase in the percentage of cells in cycle
TABLE II BrdU incorporation rates amongst CD3þ thymocytes
Cell population FVB6 weeks FVB6 months K14E76 weeks K14E76 months
CD4lo 11.8 ^ 0.0 43.6 ^ 2.2 0.6 ^ 0.2 0.8 ^ 0.1
CD4hi 1.0 ^ 0/1 5.2 ^ 0.3 2.1 ^ 0.3 2.6 ^ 0.0
DPlo 0.6 ^ 0.1 13.5 ^ 1.2 0.1 ^ 0.0 0.3 ^ 0.0
DPhi 0.7 ^ 0.1 1.9 ^ 0.2 0.6 ^ 0.0 0.9 ^ 0.1
Whole thymus 0.9 ^ 0.1 0.2 ^ 0.2 0.1 ^ 0.0 0.2 ^ 0.1
Mice were given BrdU through ip injection 1 and 5 h prior to thymus harvest. BrdU incorporation was expressed as % population BrdU FITC þve, calculated as the mean ^ 1
S.D. from three separate mice per age and per strain. Thymocytes were triple stained with CD3, CD4 and CD8 and the only the CD3 positive cells used for analysis. The low
representation of the CD8 population within the K14E7 thymus made a comparison of BrdU incorporation rates for this population unreliable, the results have therefore not
been included.
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FIGURE 4 Apoptosis is increased in the K14E7 CD4þ and CD8 þ thymic populations. (A and B) Thymic cell preparations from FVB and K14E7
mice were stained with biotinylated CD4/Streptavidin APC and CD8 FITC and then incubated in an AAD staining solution. The AAD staining of
populations expressing different levels of CD4 and CD8 were compared to determine whether marker downregulation was reflected in a change in the
level of apoptosis in the tg mice and is shown as (A) Percentage of AAD incorporation and (B) Absolute numbers of AAD positive cells. Cells were gated
on CD4 and CD8lo and CD8hi populations as shown in Fig. 3 to provide estimates of apoptosis in the populations expressing different levels of these
surface markers. (C) Single cell suspensions of K14E7 and FVB whole thymii or enriched TEC preparations were stained using a TUNEL assay to
examine the contribution made by thymic epithelia to the overall level of apoptosis shown in whole thymus preparations. (D) Cell cycle status of different
thymic subpopulations was compared between the K14E7 (K) and non-transgenic FVB (F) mice by staining thymic cell preparations using anti-CD4 and
-CD8 surface marker antibodies followed by propridium iodide staining of nuclear DNA. All data shown are the mean results for four mice assayed
separately. Three month old mice were used throughout.
TABLE III Migration of FITC-labeled thymocytes to the inguinal LN in 3 month old mice
A B C A £ B/C D A £ B/C/D £ 100
Mouse
Cell of
interest
% F+ in LN
(Mean ^ S.E.)
Number of
cells of interest
per LN ( £ 105)
(Mean ^ S.E.)
Labeling
of cell of
interest in
thymus (%)
Number of
F+ cells
of interest
in LN
at 24 h
Number of
cells of
interest in
thymus
( £ 106)
Rate of accumulation
of (or presence of) F+
migrant population
in LN at 24 h relative
to potential emigrants
population in thymus (%)
FVB CD4lo 0.51 ^ 0.08 0.44 ^ 0.18 33.75 ^ 3.10 657 0.05 ^ 0.01 1.12
K14E7 CD4lo 0.31 ^ 0.15 1.96 ^ 0.31 34.83 ^ 9.28 1740 3.77 ^ 2.82 0.04
FVB CD4hi 0.45 ^ 0.09 9.0 ^ 2.60 32.21 ^ 6.35 12 600 4.41 ^ 2.02 0.29
K14E7 CD4hi 0.67 ^ 0.31 11.4 ^ 5.70 39.71 ^ 12.40 19 200 23.70 ^ 12.80 0.08
FVB All T cells 0.42 ^ 0.07 20.0 ^ 1.00 45.15 ^ 2.70 18 600 15.20 ^ 8.50 0.12
K14E7 All T cells 0.41 ^ 0.13 27.60 ^ 1.70 45.60 ^ 3.38 24 800 162.0 ^ 89.0 0.02
Calculations are expressed as the Mean ^ S:E: for 5–6 mice per strain.
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(Penit et al., 1995). When the TN compartment was
stained for CD44 and CD25 expression followed
by PI incorporation, cell cycle status of the TN stages
could be determined. More cells in G0/G1 were
observed amongst the CD44lo TN1 cells in transgenic
animals (14.54 ^ 1.1%) than non-transgenic animals
(3.57 ^ 0.3%), with only 1.19 ^ 0.12% of K14E7
CD44lo TN1 cells being in the actively dividing G2/M
phase compared to 10.19 ^ 0.5% of CD44lo TN1 cells in
the non-tg mice. A greater percentage of K14E7 TN1 cells
were undergoing apoptosis (48.16 ^ 4.7% in the K14E7
tg TN1 as compared to 27.11 ^ 2.5% in the non-tg TN
FIGURE 5 Increased CD44 þ CD252 (TN1) cells in the K14E7 tg thymus. Collagenase digested thymii were stained with anti-CD44 PerCp,
anti-CD25 FITC, anti-CD11b APC and anti-CD3 APC. CD11b and CD3 positive cells were gated out to exclude CD44 þ macrophages and
CD44þ CD3þ activated T cells. (A) The distribution of TN cells amongst the four subpopulations were compared between young (3 month old) and old
(9 month old) non-tg and tg mouse thymii. (B and C) Cell-surface marker expression of CD25 and CD44 within the TN compartment of 9 month old FVB
and K14E7 mice. The data shown in these two figures are for a single FVB and a single K14E7 mouse representative of four experiments performed in
the same way.
FIGURE 6 CD44 þ CD252 (TN1) cells have an increased rate of apoptosis in the K14E7 tg mouse. Thymic cell preparations from 3 month old FVB
and K14E7 mice were stained with CD44 PerCP and CD25 FITC and then sorted into TN1, TN2, TN3 and TN4 populations, which were then incubated
with AAD. Uptake of this dye was used as a measure of apoptosis. (A) The most highly represented K14E7 TN population (CD44þ CD252) had an
increased level of AAD incorporation over the same population in the non-tg mouse. This increase in AAD incorporation was also shown for the final TN
phase. (B) When the number of cells incorporating AAD was compared between tg and non-tg mice, there was a substantial increase in the number of
dead and dying cells at all stages.
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compartment, suggesting that TN1 cells were being
retained in this early compartment, becoming inactive and
subsequently dying. Thus, expression of the K14E7
transgene affects maturation not only of late stage T cells
but also of an early pre T compartment.
Expanded Areas of Fibroblasts Lie Close to Densely
K14 Positive Areas in the tg Mouse
The structure of the thymus was examined in K14E7 tg
and non-tg animals. Various areas of the tg thymus
(K8þ, K14þ, CD3þ and fibroblast rich areas) were more
sharply demarcated than in the non-tg thymus. Large
blood vessels in the medullary area of the tg thymus
were surrounded by accumulations of T cells, which
were in turn surrounded by densely packed K14þ TEC
(Fig. 7A). K14þ areas were more compact than in non-tg
mice where K14þ cells were scattered through the
medullary stroma and were associated with intermediate-
sized blood vessels. T cells were seen in smaller
perivascular cuffs or evenly distributed throughout the
stroma in the non-tg mouse thymus. BrdU incorporation
was predominately in the CD32 K142 cortical stromal
areas in the K14E7 mouse, as in the FVB mouse
(Fig. 7A,B).
In the K14E7 tg mouse there were pockets of K8þ cells
which were quite separate from the K14þ cells
(Fig. 7C). The K14þ areas and the cells they encircled
showed significant BrdU incorporation, though not as
intense as the BrdU staining in the K82 cortical areas. The
pocketed K8 staining was not shown in non-tg mice
(Fig. 7D), where there was significant overlap and
interspersion of K14þ and K8þ cells.
Dense K14þ cuffs of cells were seen perivasculary,
adjacent to and surrounding areas staining strongly
positive to MTS15, a fibroblast-specific marker (Fig. 7E).
Fibroblasts accumulations also stained positive for the
intracellular fibroblast marker, MTS7. In the non-tg
mouse thymus, MTS7 and MTS15 staining was confined
to scatterings throughout the medullary areas, staining most
strongly at lobe junctions and in single layers perivascularly
(Fig. 7F). These expanded fibroblast pockets surrounded
smaller medullary blood vessels in the tg thymus and were
themselves surrounded by K14þ cells.
The MTS7/15 positive areas incorporated BrdU at a rate
similar to that of the K14þ cells in the transgenic thymus
(Fig. 7G).
MTS6 staining, indicative of MHCII expression on
cortical epithelium appeared similar in the tg and non-tg
mice. BrdU incorporation in MTS6 staining areas was
high in both, (data not shown) indicative of the high rate of
immature T cell proliferation expected in the cortical area
(Fehling and von Boehmer, 1997).
DISCUSSION
Expression of the oncogenic HPV16E7 tg, targeted to
thymic medullary epithelial cells by a K14 promoter,
induces profound thymic hyperplasia in these transgenic
mice. Epithelial cells constitute a major component of the
thymic stroma and previous work has illustrated their
importance both in thymus organogenesis and thymocyte
maturation (Anderson et al., 1993). The thymic niche
model (Berzins et al., 1999) suggests that the thymic
stroma create a microenvironment capable of supporting
the development and longevity of a certain number of
T cells, any expansion of this microenvironment providing
additional T cell niches and subsequently sustaining larger
thymic T cell populations. Choreographed maturation of
epithelia and thymocytes has been reported in several
studies (Boyd et al., 1993; van Ewijk et al., 1994;
Anderson et al., 1996) and the expansion of early stage
TEC is accompanied by enhanced support of the early
stage T cell development in mice such as the K5-cyclin D1
and K5-HPV16E6/E7 tg mice (Klug et al., 2000; Carraresi
et al., 2001). Targeted expression of the HPV 16E7
oncoprotein to squamous epithelium results in malignant
transformation and hyperplasia of the epithelial cells
(Arbeit et al., 1994). In the K14E7 tg mice described here
it could be thus expected that the expression of the
oncogenic E7 protein in the thymic epithelium of the tg
mice would induce a selective expansion of the mature
K14þ TEC compartment. Thymocyte development could
then be more rapidly driven through the DP and SP stages
due to enhanced availability of late-stage microenviron-
mental niches. The E7 mediated expansion of
the medullary epithelium in our mice has led to not only
FIGURE 7 Immunofluorescence of frozen sections from 6 month old FVB and K14E7 thymii shows increased compartmentalization of keratin-
staining, T cell and fibroblast areas in the transgenic thymus. Mice had received two doses of BrdU (5 and 1 h prior to thymus harvest) to allow an
analysis of proliferation. BrdU-FITC incorporation (green) is most intense in the cortical area (c) of both K14E7 (A) and FVB (B) thymii
(Magnigication £ 100). Keratin 14-staining (blue) encircles area of mature T cells (CD3-red) which accumulate around large blood vessels. K14E7 mice
have more densely packed K14þ areas, these areas incorporated BrdU at a higher level than do the more scattered K14þ areas of the FVB thymus.
(C) Keratin 8 (red) compartmentalization is clearly shown as distinct from the K14þ areas (blue) of this K14E7 thymus (Magnification £ 400). The
majority of BrdU incorporation (green) occurs outside the K8 þ /K14þ areas, however, a significant proportion is detected in K14þ areas and the areas
encircled by K14þ cells. (D) The FVB thymus has less discrete bundles of K14þ (orange) and K8 þ (green) epithelium. Extensive overlap occurs and
the breakdown of architectural compartmentalization which occurs with age is apparent (Magnification, £ 400). (E) Keratin (k) encircled fibroblast
pockets (f) are dispersed through the K14E7 thymus. The use of fibroblast specific MTS15 antibody (green) on sections of the K14E7 thymus, shows
these keratin-enclosed areas to clearly partitioned from the rest of the medulla. A pankeratin marker (red) is used in this section (Magnification £ 100).
(F) There is no similar compartmentalization of fibroblast accumulations in an equivalent preparation of FVB thymus. (G) The rate of cell cycling in
these K14E7 fibroblast pockets was shown through the detection of BrdU incorporation (green). The keratin surrounding the fibroblast accumulations
was shown to be keratin 14 (blue). MTS-7 (red) was used as an alternative fibroblast-specific antibody. BrdU incorporation was predominately confined
to the cortical areas (c) with lower levels of proliferation occurring in these K14þ or MTS-7þ areas.
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the support of mature T cells in the tg thymus but also to a
relative reduction in their export to the periphery.
Additional downstream events such as the expansion of
a fibroblast population adjacent to the K14þ epithelium
and a skewing of the cells in the TN pre T cell
compartment to the earlier TN stages were also observed.
There is controversy in the literature regarding the
thymic pattern of K14-promoted transgenic antigen
expression. Although endogenous K14 expression is
restricted to medullary epithelium (Klug et al., 1998),
the K14 promoter has been shown to direct transgenic
antigen expression to both the cortical and medullary
thymic cells (McGargill et al., 2000), to medullary and not
cortical regions of the thymus (Burns et al., 1999) and to
thymic cortical but not medullary epithelium (Laufer et al.,
1996). This latter paper used a K14 promoter to target
expression of a transgenic class II MHC antigen (I-Ab) to
stratified squamous epithelium. Detection of the tg relied
upon simultaneous expression of transgenic and endo-
geneous class II MHC in order that the tg I-Ab was
detected with their anti-class II heterodimer antibody.
I-Ab expression is not, however, homogeneous through
TEC in the thymus (Surh et al., 1992; Humblet et al.,
1994; Kasai et al., 1996), MHC class II complexes being
shown to be less stable in medullary TEC than in cortical
TEC (Kasai et al., 1996). Thus the absence of I-A
detection in the medullary region of tg mice described in
this paper may merely reflect the instability of medullary
I-Ab as opposed to definitively locating K14-promoted tg
expression, which was not the purpose of the study. In
contrast, K14-B7.1 tg mice which use the same K14
promoter used to create our K14E7 tg mice, showed tg
B7.1 expression as being limited to the medullary
epithelium (Burns et al., 1999). The medullary staining
pattern observed in these K14 B7-1 tg mice corresponded
to the pattern of CD80 expression reported by others for
normal thymic tissue (Nelson et al., 1993; Degermann
et al., 1994). Our histological comparison of K14þ areas
in the non-tg and K14E7 tg thymii showed a more densely
packed medulla and more dense expression of medullary
K14 in the tg mice. Secondary effects of K14-promoted
E7 expression such as K14-encircled fibroblast pockets
were also confined to the medullary area. Our data are thus
consistent with E7 tg expression being targeted to
medullary epithelium by our K14 promoter.
Recent papers have suggested that the progress of
thymocytes through the maturation and selection process
is determined not only upon the expression of certain cell
surface markers but also upon the intensity of this
expression (McKean et al., 2001). We were able to
correlate the level of T cell marker expression in the
K14E7 mouse with thymic size and also the rate at which
the cells died, divided and migrated to the periphery.
Within the CD3þ population the CD4 and CD8 markers
were noticeably downregulated in the tg mouse from as
early as 6 weeks old, the downregulation of CD44 in the
TN population appearing only as the mice reached later
life. The retained, predominately CD4lo cells were distinct
from the recently described CD25þ CD4þ suppressor
T cells (Takahashi et al., 1998; Itoh et al., 1999) in that
they are CD3 bright and TCRþ, having already passed
through TCR rearrangement and selection. Whilst a
reduced level of expression of CD4 and CD8 on mature
thymocytes is usually indicative of cells preparing for
apoptotic death (Tiso and Gangemi, 1995), the non-
cycling CD4lo and CD8lo cells retained in the K14E7
thymus had a reduced level of apoptosis. We have
therefore shown that the downregulation of cell surface
marker expression that normally accompanies pro-
grammed cell death is a distinct pathway that can occur
independently of apoptotic death. It has been shown that
the presence of mature CD4þ cells plays a feedback role in
the developmental signaling provided to the TN
population (Fridkis-Hareli et al., 1994; Mehr et al.,
1996). The observed accumulation of mature SP
thymocytes in our K14E7 mice must, therefore, reach a
critical number at which feedback inhibition begins to
cause the accumulation of early TN stages at the expense
numbers of cells in the later TN4 stage. The down-
regulation of CD44 in the TN1 and TN2 population is
once again indicative of older, accumulating cells and can
be considered a secondary event to SP cell accumulation
in the older tg thymus.
Scollay and Godfrey proposed two opposing models of
thymocyte exit from the thymus (Scollay and Godfrey,
1995): (Gabor et al., 1997b) the conveyor belt model
whereby thymocytes pass through obligatory maturation
stages and are exported as SP cells expressing the full
complement of maturational markers, and (Utsuyama
et al., 1991) the stochastic model whereby thymocytes
spend a variable length of time in the medulla, acquiring
phenotypic markers of maturation and leaving for the
periphery at any stage during the maturational process.
Our data tend to comply with the former model and the
data of Chaffin and Perlmutter (1991) and Gabor et al.
(1997b) which suggest that export from the thymus is the
result of an active and regulated process dependent upon
the cells having attained a certain stage of maturation and
expressing appropriate levels of emigration-related
signals. The higher level of expression of CD69 and
CD5 in the K14E7 tg thymus is suggestive that the stromal
signaling which controls post selection survival and exit
from the thymus is being skewed by the expression of E7.
It could be suggested that, due to the larger number of
niches available for mature T cells, fewer SP T cells are
receiving adequate stromal signaling and are less able to
leave the tg thymus for the peripheral T cell pool, these
cells merely wait to die in the thymus.
In our system, densely packed K14þ epithelium,
smaller pockets of K8þ epithelium and unique fibroblast
pockets were observed. A high level of compartmentaliza-
tion of the thymic medulla into epithelial islets is
characteristic of a juvenile thymus, the thymic structure
generally deteriorating with age in normal mice
(Rodewald et al., 2001). A previous study comparing
thymic development in the FVB strain to age- matched
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mice of other strains, showed that the FVB thymus
undergoes premature thymic involution, showing loss of
thymic architecture and loss of epithelial morphological
differentiation 5 months earlier than other commonly used
mouse strains (Nabarra et al., 2001). The failure of the
K14E7 thymus to involute and the significantly more
defined thymic architecture in the adult tg mouse, suggests
the presence of the transgene prevents the early aging
shown by the FVB strain, maintaining a large cortical
presence, clear compartmentalization and epithelial
differentiation. Signals derived from K14 TEC are thus
crucial to the control of age-related thymic involution and
structural deterioration.
Since the niche model was proposed a more complex
picture of thymic homeostatic regulation has emerged.
Elements crucial to the control of T cell development
within the thymic microenvironment include TEC- and
fibroblast-derived cytokines such as IL7, SCF, TGFb and
TNFa which must be produced in adequate levels in order
that cells may progress through crucial TN, DN and DP
checkpoints. The stromal cell dependency of the
thymocyte subsets varies markedly, with the CD44þ TN
stages being most dependent upon input from MHC class
IIþ TEC and fibroblasts (Anderson et al., 1997). Cytokines
are also required to signal the upregulation of markers
which will allow the cells to exit the thymus and be
transported to the periphery (Diamond et al., 1997; Gabor
et al., 1997b; Porcellini et al., 1999). An E7-induced
alteration in the thymic architecture and the maintenance
of a “younger” thymic structure could be expected to alter
the nature of the thymocyte-stromal cell interactions and
the levels of cytokines to which the developing
thymocytes are exposed. We postulate that, in the
K14E7 mouse, the altered growth of K14þ-expressing
epithelium under the direction of the oncogenic E7 protein
leads to a change in the thymic architecture and
composition such that cells important to the maturational
process are altered in their relative abundance or contact
with each other. This altered medullary composition is
able to support DP to SP transitions and TCR mediated
selection but appears to have a reduced ability to induce
final export readiness or alternatively, produces a
microenvironment containing levels of chemokines
which result in thymocyte longevity and/or retention.
Although there have been several reports demonstrating
the affect of the cytokine mix in the stroma on the ability
of thymocytes to progress normally through to mature SP
cells (Porcellini et al., 1999), this is the first report
whereby an altered thymic microenvironment is able to
effect the export of thymocytes to the peripheral T cell
pool. As the thymocytes from these tg mice age without
being exported they downregulate their markers but do not
automatically enter the apoptotic pathway. Thus the
immortalisation of a TEC population through the
expression of a tg which is not expressed in thymocytes
is able to prevent thymic involution. The number of cells
in the thymus (thymocytes and stroma) increases
dramatically without grossly disturbing the balance of
T cells in the thymus or the structure or function of
the peripheral immune system, with the exception of a
deletion of CD8 T cells specific for E7 (Frazer et al.,
1998). The expansion of the K14E7 thymic T cell
population was reflected in a 50% increase in the
peripheral T cell population. This concurs with the
findings of Berzins et al. (1999) whereby severely
hyperthymic mice were able to overcome the usual
homeostatic control over the number of peripheral T cells.
The degree to which the failure to involute, the
accumulation of mature thymic T cells and other ageing-
related events, such as the age-related loss of immune
function, are interdependent can thus be explored with our
K14E7 tg mouse model. Preliminary data has shown that
the observed downregulation of CD4 and CD8 expression
and thymic hypertrophy is due to the secretion of soluble
factors by the K14E7 TEC population (paper in
preparation). Further work is underway to isolate these
cellular products and to determine the nature of the
thymocyte/stromal cell interactions involved in the
abnormal maturational outcomes observed in the K14E7
tg thymus.
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